guhjy's pparg [96 articles] Export Sort

Recent papers added to guhjy's library classified by the tag pparg. You can also see everyone's pparg.

Hide details

	PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. [My Copy] American journal of physiology. Heart and circulatory physiology, Vol. 290, No. 1. (January 2006) by Karim Benkirane, Farhad Amiri, Quy N. Diep, Mohammed El Mabrouk, Ernesto L. Schiffrin posted to ship pparg erk akt aii 4ebp by guhjy on 2009-12-21 14:41:47 as
	Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3beta, Snail1, and beta-catenin in renal proximal tubule cells. [My Copy] American journal of physiology. Renal physiology (16 December 2009) by Yu Jin J. Lee, Ho Jae J. Han posted to snail sglt ros pt pparg pi3k hg gsk3 emt catenin akt 1 by guhjy on 2009-12-21 04:12:52 as
	Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice [My Copy] Diabetes, Vol. 58, No. 9. (September 2009), pp. 1986-1997. by Heiko Bugger, Dong Chen, Christian Riehle, et al.Jamie Soto, Heather A. Theobald, Xiao X. Hu, Balasubramanian Ganesan, Bart C. Weimer, E. Dale Abel posted to pparg pgc1 mt dm by guhjy on 2009-12-21 01:53:28 as
	Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis. [My Copy] Cochrane database of systematic reviews (Online), No. 1. (2007) by F. Angelico, M. Burattin, C. Alessandri, M. Del Ben, F. Lirussi posted to pparg nash metformin by guhjy on 2009-12-20 04:10:21 as
	PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells. [My Copy] Acta pharmacologica Sinica, Vol. 30, No. 1. (January 2009), pp. 107-112. by Wei-ming M. Wang, Hui-di D. Zhang, Yuan-meng M. Jin, Bing-bing B. Zhu, Nan Chen posted to tgfb pt pparg chemokine by guhjy on 2009-12-11 03:20:01 as
	An Emerging Role of mTOR in Lipid Biosynthesis [My Copy] Current Biology, Vol. 19, No. 22. (01 December 2009), pp. R1046-R1052. by Mathieu Laplante,, David .. Sabatini, posted to srebp pparg mtor 1 by guhjy on 2009-12-09 15:57:53 as
	Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling. [My Copy] Autophagy, Vol. 6, No. 1. (27 January 2010) by Jinguo Yan, Huaiyi Yang, Gang Wang, et al.Lei Sun, Yuguang Zhou, Yinglu Guo, Zhijun Xi, Xuejun Jiang posted to pparg egfr autophagy ampk by guhjy on 2009-12-01 08:51:06 as
	Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. [My Copy] British journal of pharmacology (16 November 2009) by Chun Liang, Yusheng Ren, Hongbin Tan, et al.Zhiqing He, Qijun Jiang, Jianxiang Wu, Yi Zhen, Min Fan, Zonggui Wu posted to pparg nos epc akt age by guhjy on 2009-11-22 08:02:40 as
	Regulation of PPARgamma function by TNF-alpha. [My Copy] Biochemical and biophysical research communications, Vol. 374, No. 3. (26 September 2008), pp. 405-408. by Jianping Ye posted to tnf pparg by guhjy on 2009-11-21 14:19:33 as
	Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. [My Copy] Free radical biology & medicine, Vol. 44, No. 6. (15 March 2008), pp. 1055-1068. by Yeoun Hee H. Kim, Eun Mi M. Jung, Tae-Jin J. Lee, et al.Sang Hyun H. Kim, Yung Hyun H. Choi, Jeen Woo W. Park, Jong-Wook W. Park, Kyeong Sook S. Choi, Taeg Kyu K. Kwon posted to trail tnf ros pparg apoptosis by guhjy on 2009-11-17 02:18:23 as
	CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone. [My Copy] Fundamental & clinical pharmacology (10 September 2009) by D. John Betteridge posted to rct pparg cv by guhjy on 2009-11-14 09:56:59 as
	Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fears. [My Copy] Nephron. Clinical practice, Vol. 112, No. 4. (2009) by Zhiguo Mao, Albert C. Ong posted to pparg ckd by guhjy on 2009-11-14 08:50:27 as
	The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 20, No. 11. (1 November 2009), pp. 2380-2388. by Hai-Chun C. Yang, Sebastien Deleuze, Yiqin Zuo, Sebastian A. Potthoff, Li-Jun J. Ma, Agnes B. Fogo posted to shc rat pparg kidney aging by guhjy on 2009-11-10 02:35:55 as
	Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications. [My Copy] Diabetes/metabolism research and reviews, Vol. 25, No. 2. (February 2009), pp. 112-126. by Andrew Krentz posted to tzd pparg dm cv by guhjy on 2009-11-04 06:07:16 as
	Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetes. [My Copy] Diabetes care (16 October 2009) by Limei Liu, Taishan Zheng, Feng Wang, et al.Niansong Wang, Yanyan Song, Ming Li, Lifang Li, Jiamei Jiang, Weijing Zhao posted to snp pparg dn chinese by guhjy on 2009-11-02 02:18:53 as
	Elevated concentrations of 15-deoxy-Delta12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor gamma-inducing drugs. [My Copy] Liver international : official journal of the International Association for the Study of the Liver, Vol. 29, No. 5. (May 2009), pp. 730-735. by Olav A. Gressner, Chunfang Gao, Katharina Rehbein, et al.Birgit Lahme, Monika Siluschek, Thomas Berg, Tobias Müller, Axel M. Gressner posted to pparg pg liver by guhjy on 2009-10-29 02:11:40 as
	The role of Sgk-1 in the upregulation of transport proteins by PPAR-gamma agonists in human proximal tubule cells. [My Copy] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 24, No. 4. (April 2009), pp. 1130-1141. by Sonia Saad, David J. Agapiou, Xin-Ming M. Chen, Veronica Stevens, Carol A. Pollock posted to sgk pt pparg by guhjy on 2009-10-21 09:53:30 as
	Transcription factors Krüppel-Like Factor 6 and Peroxisome Proliferator-Activated Receptor-gamma mediate high glucose-induced thioredoxin-interacting protein. [My Copy] The American journal of pathology, Vol. 175, No. 5. (1 November 2009), pp. 1858-1867. by Weier Qi, Xinming Chen, John Holian, Christina Y. Tan, Darren J. Kelly, Carol A. Pollock posted to pparg mc klf hg by guhjy on 2009-10-14 06:00:04 as
	Dialysis: the sweetness of glitazones: randomized trials needed. [My Copy] Nature reviews. Nephrology, Vol. 5, No. 9. (September 2009), pp. 497-498. by Carmine Zoccali posted to pparg esrd by guhjy on 2009-09-11 03:23:05 as
	Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease. [My Copy] Pharmacological research : the official journal of the Italian Pharmacological Society, Vol. 60, No. 3. (September 2009), pp. 174-178. by Sho-ichi Yamagishi, Kazuo Nakamura, Takanori Matsui posted to rage pparg cv age by guhjy on 2009-09-09 11:04:49 as
	Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial [My Copy] The Lancet, Vol. 373, No. 9681. (26 June 2009), pp. 2125-2135. by Philip D. Home, Stuart J. Pocock, Henning Beck-Nielsen, et al.Paula S. Curtis, Ramon Gomis, Markolf Hanefeld, Nigel P. Jones, Michel Komajda, John J. V. McMurray posted to risk-difference rct pparg dm cv by guhjy on 2009-09-07 10:59:16 as along with 2 people ggrassi booker
	Peroxisome proliferator-activated receptors and angiogenesis. [My Copy] Nutrition, metabolism, and cardiovascular diseases : NMCD (22 July 2009) by F. Biscetti, G. Straface, D. Pitocco, F. Zaccardi, G. Ghirlanda, A. Flex posted to pparg angiogenesis by guhjy on 2009-08-28 05:58:35 as
	Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes. [My Copy] Acta diabetologica, Vol. 46, No. 1. (March 2009), pp. 27-33. by Sudarshan K. Vijay, Manish Mishra, Hemant Kumar, K. Tripathi posted to pparg enddysf dm by guhjy on 2009-08-28 05:57:58 as
	Rosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells. [My Copy] Experimental diabetes research, Vol. 2009 (2009) by Catharine Whiteside, Hong Wang, Ling Xia, Snezana Munk, Howard J. Goldberg, I. George Fantus posted to col4 vegf pparg mc hg collagen by guhjy on 2009-08-25 09:55:24 as
	Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator. [My Copy] The FASEB journal : official publication of the Federation of American Societies for Experimental Biology (24 April 2009) by Asish K. Ghosh, Swati Bhattacharyya, Jun Wei, et al.Suyeon Kim, Yaacov Barak, Yasuji Mori, John Varga posted to smad pparg p300 collagen by guhjy on 2009-07-17 16:07:11 as
	Human scavenger receptor class B type 1 is regulated by activators of peroxisome proliferators-activated receptor-gamma in hepatocytes. [My Copy] Endocrine, Vol. 35, No. 2. (April 2009), pp. 233-242. by R. A. Ahmed, K. Murao, H. Imachi, et al.X. Yu, J. Li, N. C. Wong, T. Ishida posted to pparg srb1 by guhjy on 2009-07-17 15:10:29 as
	The peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. [My Copy] Molecular and cellular biology, Vol. 29, No. 13. (July 2009), pp. 3544-3555. by K. Wakabayashi, M. Okamura, S. Tsutsumi, et al.N. S. Nishikawa, T. Tanaka, I. Sakakibara, J. Kitakami, S. Ihara, Y. Hashimoto, T. Hamakubo, T. Kodama, H. Aburatani, J. Sakai posted to h4k20 pparg set by guhjy on 2009-07-17 15:05:33 as
	Cyclin D1 inhibits PPARgamma -mediated adipogenesis through HDAC recruitment [My Copy] J. Biol. Chem. (14 February 2005), M500403200. by Maofu Fu, Mahadev Rao, Toula Bouras, et al.Chenguang Wang, Kongming Wu, Xueping Zhang, Zhiping Li, Tiso-Pang Yao, Richard G. Pestell posted to cyclin-d1 hdac pparg suv39h1 by guhjy on 2009-07-15 16:37:24 as
	Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation. [My Copy] Protein and peptide letters, Vol. 15, No. 8. (2008), pp. 850-853. by S. Yamagishi, T. Matsui, K. Nakamura, M. Takeuchi, H. Inoue posted to arb endothelium pparg rage by guhjy on 2009-06-22 16:14:18 as
	Emerging therapies for chronic kidney disease: what is their role? [My Copy] Nature reviews. Nephrology, Vol. 5, No. 7. (19 July 2009), pp. 375-383. by Eswari Vilayur, David C. Harris posted to pparg pkc inhibitor ckd age by guhjy on 2009-06-21 02:50:47 as
	Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation. [My Copy] Biochemical and biophysical research communications, Vol. 385, No. 2. (24 July 2009), pp. 269-272. by Takanori Matsui, Sho-ichi Yamagishi, Masayoshi Takeuchi, Seiji Ueda, Kei Fukami, Seiya Okuda posted to ros rage pparg mc ccb age by guhjy on 2009-06-21 02:50:33 as
	Rosiglitazone is associated with mortality in chronic hemodialysis patients. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 20, No. 5. (May 2009), pp. 1094-1101. by S. P. Ramirez, J. M. Albert, M. J. Blayney, et al.F. Tentori, D. A. Goodkin, R. A. Wolfe, E. W. Young, G. R. Bailie, R. L. Pisoni, F. K. Port posted to hd mortality pparg by guhjy on 2009-06-20 05:22:33 as
	Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 1. (1 January 2009), pp. 2-8. by F. Ondrey posted to cancer pparg by guhjy on 2009-06-09 09:59:52 as
	Efficacy and safety of pioglitazone: The proactive study [My Copy] International Congress Series, Vol. 1303 (August 2007), pp. 155-159. by P. Brunetti posted to pparg proactive rct by guhjy on 2009-05-27 07:43:38 as
	PROactive study [My Copy] The Lancet, Vol. 367, No. 9504. (13 January 2006), pp. 24-25. by J. Yudkin, N. Freemantle posted to pparg proactive rct by guhjy on 2009-05-27 07:39:03 as
	Troglitazone suppresses transforming growth factor-1-induced collagen type I expression in keloid fibroblasts [My Copy] British Journal of Dermatology, Vol. 160, No. 4., pp. 762-770. by G. -. Y. Zhang, C. -. G. Yi, X. Li, et al.B. Ma, Z. -. J. Li, X. -. L. Chen, S. -. Z. Guo, W. -. Y. Gao posted to collagen fbl pparg tgfb by guhjy on 2009-05-12 09:18:53 as
	Rosiglitazone protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression. [My Copy] Diabetes, obesity & metabolism, Vol. 11, No. 5. (May 2009), pp. 519-522. by X. M. Yao, S. D. Ye, Y. Chen, et al.Z. M. Zai, X. C. Li, Y. X. Wang, K. Chen posted to dn mmp pparg rat stz by guhjy on 2009-05-10 04:35:20 as
	Emerging role of PPAR ligands in the management of diabetic nephropathy. [My Copy] Pharmacological research : the official journal of the Italian Pharmacological Society, Vol. 60, No. 3. (31 September 2009), pp. 170-173. by Pitchai Balakumar, Mandeep Kumar K. Arora, Manjeet Singh posted to dn pparg by guhjy on 2009-04-26 10:45:39 as
	Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. [My Copy] Diabetes, Vol. 54, No. 7. (July 2005), pp. 2206-2211. by F. Pistrosch, K. Herbrig, B. Kindel, J. Passauer, S. Fischer, P. Gross posted to dm hyperfiltration pparg uae by guhjy on 2009-03-30 12:34:42 as
	Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone. [My Copy] American heart journal, Vol. 156, No. 1. (July 2008), pp. 23-30. by A. V. Hernandez, E. Walker, J. P. Ioannidis, M. W. Kattan posted to cv meta-analysis pparg by guhjy on 2009-03-16 01:57:00 as
	Bioactive lipids in metabolic syndrome. [My Copy] Progress in lipid research, Vol. 47, No. 2. (March 2008), pp. 127-146. by K. Nagao, T. Yanagita posted to irs lipid-signaling pparg by guhjy on 2009-03-05 08:50:53 as
	Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex. [My Copy] FEBS letters, Vol. 582, No. 1. (9 January 2008), pp. 32-38. by O. Ziouzenkova, J. Plutzky posted to pparg by guhjy on 2009-03-05 08:50:26 as
	PPAR gamma and human metabolic disease. [My Copy] The Journal of clinical investigation, Vol. 116, No. 3. (March 2006), pp. 581-589. by R. K. Semple, V. K. Chatterjee, S. O'Rahilly posted to pparg by guhjy on 2009-03-05 08:47:59 as along with 2 people hendryluis care100
	Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. [My Copy] Head & neck, Vol. 30, No. 6. (June 2008), pp. 800-809. by H. Hamakawa, K. Nakashiro, T. Sumida, et al.S. Shintani, J. N. Myers, R. P. Takes, A. Rinaldo, A. Ferlito posted to cancer cox2 egfr oral pparg targeted-therapy by guhjy on 2009-03-04 03:41:14 as
	Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. [My Copy] Mediators of inflammation, Vol. 2007 (2007) by W. Wang, F. Liu, N. Chen posted to emt nrk49f pparg tgfb by guhjy on 2009-02-28 16:21:49 as
	Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone. [My Copy] Clinical trials (London, England), Vol. 5, No. 2. (2008), pp. 116-120. by I. J. Dahabreh, K. Economopoulos posted to cv meta-analysis pparg by guhjy on 2009-02-07 03:13:56 as
	Integration of metabolism and inflammation by lipid-activated nuclear receptors [My Copy] Nature, Vol. 454, No. 7203. (23 July 2008), pp. 470-477. by Steven J. Bensinger, Peter Tontonoz posted to dm inflammation pparg by guhjy on 2009-01-29 01:36:13 as along with 2 people fisherp amromeo
	How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events? [My Copy] BMJ, Vol. 331, No. 7520. (8 October 2005), pp. 836-838. by Nick Freemantle posted to cv dm pparg proactive rct by guhjy on 2009-01-25 14:49:39 as
	PROactive: A Sad Tale of Inappropriate Analysis and Unjustified Interpretation [My Copy] Clin Diabetes, Vol. 24, No. 2. (1 April 2006), pp. 63-65. by Jay S. Skyler posted to cv dm pparg proactive rct by guhjy on 2009-01-25 14:46:26 as
	Genetic prediction of the metabolic syndrome [My Copy] Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 2, No. 4. (December 2008), pp. 245-252. by V. Lyssenko, M. Sjogren, P. Almgren, et al.D. Anevski, M. Orhomelander, B. Isomaa, T. Tuomi, M. Taskinen, L. Groop posted to irs pparg snp by guhjy on 2009-01-17 05:49:04 as

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/tag/pparg

Result page: 1 2 Next

ckd	1738
rct	1203
dn	1146
dm	1046
cancer	1044
ma	979
cv	926
hd	859
tgfb	841
snp	772
ros	661
bp	644
meta-analysis	516
kidney	507
uae	501
mouse	493
stats	480
software	463
mirna	450
pt	449
genetics	449
proteomics	412
mortality	408
rat	390
fbl	379
tw	373
inflammation	371
proteinuria	356
pcr	353
akt	346
mtor	346
mc	343
1	340
db	337
acei	334
gdl	331
irs	326
test	325
inhibitor	324
method	323
urine	320
arb	316
apoptosis	314
aging	311
age	311
ms	310
hcv	304
aii	299
r	294
biomarker	287
hg	285
ppi	282
bias	277
pi3k	276
bayes	275
gwa	270
aki	269
s6k	262
emt	260
nutrition	255
rnai	249
egfr	249
p53	243
ub	242
obesity	236
fibrosis	236
erk	232
cox	229
smad	228
drug	225
pbmc	223
hcc	216
metab	214
hypoxia	212
gn	210
nfkb	205
herb	204
stz	196
collagen	192
albumin	189
lc	187
hif	184
longitudinal	179
pubmed	179
lmm	178
pkc	175
gfr	174
p38	173
ua	170
epigenetics	169
bioinf	166
japan	165
power	163
cea	163
rage	162
gender	162
dna-damage	161
lead	160
cadmium	158
ref	154
genomics	151
vitamin-d	148
ctgf	147
stata	147
liver	146
book	146
network	146
company	144
screening	137
diet	136
rt	136
phosphorylation	135
mt	133
seq	133
kinase	128
go	128
protein	127
pathway	127
cell-cycle	126
no	126
esrd	124
systems-biology	124
insulin	122
lipid	118
creatinine	117
statin	117
proliferation	113
senescence	109
mapk	109
stat	106
podocyte	106
fish	104
tnf	104
regression	103
gfr-formula	102
cad	102
pd	102
case-control	102
hypertrophy	101
imputation	101
nox	100
multiplicity	100
imaging	100
rx	99
p21	98
observational	98
sirt	97
methylation	96
pediatric	96
pparg	96
cloning	96
plasmid	96
at1	95
recurrent	94
betel	93
blood	93
chf	91
src	90
nhanes	90
website	89
anemia	88
phenotype	88
immunity	88
ko	88
diagnosis	87
toxicology	86
review	86
lr	86
uti	85
gene-therapy	84
epo	84
ebm	84
cytokine	84
china	83
environment	82
ca	81
nonp	81
oat	81
cachexia	81
p	81
hapmap	80
gout	78
autophagy	78
primer	78
qms	77
signaling	75
egf	75
missing	73
promoter	73
ace	73
eif	73
cox2	73
stone	72
lpd	72
surrogate	72
eqtl	72
gene-list	72
gpcr	72
mv	71
p-value	71
col4	71
ampk	71
4ebp	71
salt	70
phd	69
foxo	69
jnk	69
mgo	68
glycemia	66
uncertainty	66
hts	65
chinese	65
pe	65
uuo	65
mirna-target	65
normalization	65
tin	65
shc	64
ifn	64
association	64
enddysf	63
yeast	63
acid-base	63
2dge	63
causation	63
pla2	63
hsp	63
smoking	62
llcpk1	62
simulation	62
nrk49f	62
translation	62
me	62
avf	61
oglcnac	61
pdgf	61
confounding	61
ptm	61
mmp	60
outcome	60
infection	60
change	60
sas	60
melamine	60
pai1	59
oral	59
crp	59
cost	59
alcohol	58
hk2	58
achr	57
rho	57
pls	57
urate-transporter	57
vegf	57
model-selection	57
robust	57
fluorescence	57
aceiarb	56
rapamycin	56
semantic	56
calibration	56
competing-risk	55
goldstd	55
ratio	55
ace2	55
ncrna	55
cyclin-d1	54
workflow	54
function	54
iron	54
ckd-progression	54
stem-cell	54
bone	54
estrogen	54
hsc	53
dipstick	53
renoprotection	53
pld	53
k	53
std	53
dimerization	52
il6	52
tf	52
histone	52
atm	52
qc	52
fgf	52
ab	51
normoalbuminuria	51
epidemiology	51
hdac	51
pth	51
lod	51
matlab	50
risk-ratio	50
hepatocyte	50
arsenic	50
p27	50
graph	50
adpkd	50
reasoning	50
mercury	50
wnt	50
klotho	49
epistasis	49
gene-environment	49
antibiotics	49
core-curriculum	48
ngal	48
ukm	48
pdk	48
irs1	48
ffpe	48
endothelium	48
breakpoint	48
nrk52e	48
spot-urine	47
pooling	47
joint-model	47
mtorc1	47
aspirin	46
ras	46
hgf	46
cystatin	46
dub	46
aldosterone	46
protein-microarray	46
fdr	46
prevention	45
semip	45
fgf23	45
metal	45
biosensor	45
writing	45
dbdb	45
diuretics	44
interaction	44
ecm	44
tgfbr	44
metformin	44
variability	44
er-stress	44
ancova	44
enos	44
mesangial	44
ccb	44
sumo	44
klf	43
bia	43
sle	43
cnv	43
na	43
design	43
asia	42
bmi	42
agreement	42
good	42
roc	42
icu	42
stroke	42
fuzzy	41
qtl	41
catenin	41
vsmc	41
tlr	40
hyperfiltration	40
fibronectin	40
sage	40
alignment	40
gene-targeting	40
risk	40
wga	40
ap1	39
angiogenesis	39
urinalysis	39
dry-bw	39
rca	39
protein-complex	39
igf	39
tea	38
igan	38
myc	38
antisense	38
rvh	38
omics	38
gsk3	37
gsk	37
propensity	37
emr	37
glut	37
adh	37
fabp	37
haplotype	37
bh4	37
hematuria	37
rsk	37
mtorc2	36
snx	36
adenosine	36
proteasome	36
cardiorenal	36
megalin	36
web20	36
il1	36
animal	36
inflammasome	36
s100b	36
chemogenomics	35
sp1	35
coffee	35
candidate-gene	35
exercise	35
annotation	35
subgroup	35
cre	35
adduct	35
reverse-epidemiology	35
threshold	35
calcification	35
nephrotoxicity	34
msm	34
sglt	34
sepsis	34
creb	34
attrition	34
pathology	34
cross-species	34
effect-size	34
pka	33
ecology	33
sarcopenia	33
zeb	33
rtk	33
bmp	33
cage	33
ns	33
integrin	33
affy	32
ai	32
addgene	32
pp2a	32
steroid	32
et	32
set	32
end-point	32
text-mining	32
aa	32
browser	32
zfn	32
fc	32
macrophage	32
orbitrap	32
gllamm	31
frailty	31
family	31
silac	31
agt	31
heritability	31
hospitalization	31
emsa	31
transactivation	31
igf1	31
abp	31
blast	31
risk-difference	31
mw	30
membrane-protein	30
reporter	30
transporter	30
notch	30
grn	30
pten	30
carcinogen	30
s100	30
cr	30
knockout	30
staging	30
geo	30
ub-ligase	29
3	29
perindopril	29
nicotinic	29
validation	29
nutrient	29
virus	29
human	29
sgk	29
extraction	29
renin	29
pharmacogenetics	28
race	28
mutagenesis	28
time-dependent	28
acetylation	28
gee	28
hplc	28
thesis	28
scaling	28

guhjy's pparg [96 articles] Export Sort

guhjy's tags